|
|
|
|
|
||
| Site Map | HHS Privacy Statement | Contact Us | Danya Learning Center | ||
| Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment. | ||
| Last updated: September 20, 2002. | ||
|
Buprenorphine in the Treatment of Opioid Dependence |
|
| Home > Resources > Bibliography > Special Treatment Populations: Renal Failure Patients | |
Special Treatment Populations: Renal Failure PatientsHand CW, Sear JW, Uppington J, Ball MJ, McQuay HJ, and Moore RA. Buprenorphine disposition in patients with renal impairment: Single and continuous dosing with special reference to metabolites. British Journal of Anaesthesia (74):276–282, 1990. Summerfield RJ, Allen MC, Moore RA, Sear JW, and McQuay HJ. Buprenorphine in end-stage renal failure. Anaesthesia (40):914, 1985. Return to the table of contents. |
|
|
|
|
|
|
||
| Site Map | HHS Privacy Statement | Contact Us | Danya Learning Center | ||
| Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment. | ||
| Last updated: September 20, 2002. | ||